Search

Your search keyword '"Deborah A. Kuban"' showing total 353 results

Search Constraints

Start Over You searched for: Author "Deborah A. Kuban" Remove constraint Author: "Deborah A. Kuban"
353 results on '"Deborah A. Kuban"'

Search Results

1. Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center

2. Patients’ Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer

3. Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

4. Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy

5. Long-term tumor control after brachytherapy for base-of-prostate cancer

6. Improving efficiency and reducing costs of MRI-Guided prostate brachytherapy using Time-Driven Activity-Based costing

7. Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy

8. Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers

9. Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data

10. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

11. Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial

12. Multidisciplinary clinics in prostate cancer

13. Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer

14. A Double-Blind, Randomized, Placebo-Controlled Trial ofPanax Ginsengfor Cancer-Related Fatigue in Patients With Advanced Cancer

15. Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

17. Determining Clinically-Based Factors Associated with Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort

18. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding

19. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer

20. Outcomes after adjuvant radiation therapy for prostate cancer at a comprehensive cancer center

21. Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network

22. Comparisons of Treatment Outcomes and Patterns of Lymph Node Involvement in T4 Prostate Cancer Patients

23. External Validation of Early Quality of Life (QOL) Declines Correlated with Late QOL after Intensity Modulated, Low Dose Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer within a Prospective Trial

24. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer

26. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer

27. PD20-10 UPGRADING AT PROSTATECTOMY FOLLOWING INITIATION OF ACTIVE SURVEILLANCE IN MEN WITH LOCALIZED PROSTATE CANCER

28. MP22-10 ONCOLOGIC OUTCOMES IN MEN WITH HIGH RISK PROSTATE CANCER ELIGIBLE FOR BOTH RADICAL PROSTATECTOMY AND RADIOTHERAPY: THE MD ANDERSON MULTIDISCIPLINARY CLINIC EXPERIENCE

29. MP17-20 IMPROVING RISK-STRATIFICATION OF LOCALIZED PROSTATE CANCER IN A PROSPECTIVE ACTIVE SURVEILLANCE COHORT

30. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance

31. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance

32. Genitourinary and gastrointestinal toxicity among patients with localized prostate cancer treated with conventional versus moderately hypofractionated radiation therapy: systematic review and meta-analysis

33. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort

34. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes

35. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer

36. Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States

37. Local recurrence map to guide target volume delineation after radical prostatectomy

38. Prospective peer review quality assurance for outpatient radiation therapy

39. Impact of a Clinical Trial Initiative on Clinical Trial Enrollment in a Multidisciplinary Prostate Cancer Clinic

40. Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial

41. Prospective Cancer Control and Patient-reported Quality of Life after Post-prostatectomy Salvage Radiation Therapy for Prostate Cancer

42. Implementation and efficacy of a large-scale radiation oncology case-based peer-review quality program across a multinational cancer network

43. Developing clinical indicators to effectively monitor a large network of radiation oncology practices

44. Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options

45. A Phase II trial of Hypofractionated Proton Therapy in Prostate Cancer: 3-year Physician and Patient Reported Outcomes

46. Factors Affecting Receipt of Non-Definitive Therapy for High-Risk Prostate Cancer: A National Cancer Database Analysis

47. Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer

48. ‘It's not like you just had a heart attack’: decision-making about active surveillance by men with localized prostate cancer

49. A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy

50. Multi-institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated With Patient-Reported Outcomes: The PROSTQA Experience

Catalog

Books, media, physical & digital resources